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Abstract
The Role of Nonmuscle Myosin IIA in Endothelial Cell
Jing Zhu
Myosins are molecular motors that convert chemical energy into mechani-
cal force. Vertebrate cells contain three myosin II isoforms, designated as
myosin IIA, IIB and IIC, and each isoform has unique biochemical and bio-
physical charasterics. It is generally accepted that all three isoforms are
involved in regulating actin structures and cell contraction. However, it is
unknown what role(s) each isoform plays in maintaining actin structures
and generating cellular force. Experiments presented in this thesis will be-
gin to document what role myosin IIA plays in endothelial cell contraction
and actin dynamics.
Myosin IIA ablated from endothelial cells by infection with adenovirus en-
coding a short hairpin interfering RNA targeting mouse nonmuscle myosin
IIA (shRNAi-IIA) mediated knockdown of myosin IIA, altered endothelial
cell shape and induced reorganization of actin filaments. Myosin IIB con-
tent was unaltered and myosin IIB remained associated with actin filaments.
Cell attachement and spreading occured faster and there was an increase in
cell motility compared to control cultures. Loss of myosin IIA resulted in a
40% reduction in basal force production and a significantly blunted throm-
bin induced cell contraction. These results show myosin IIA is needed for
normal endothelial cell functions and is essential for generation of basal and
agonist-induced force.
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The vascular system is lined by a continuous sheet of endothelial cells. The individual
endothelial cell is typically a flattened, extended polygonal cell which interfaces with its
multiple neighbors through a modest variety of junctional specializations characteristic
of its site in the circulation. In vivo, the flattened state of cell abutted to cell is the
usual condition. However, under the influence of a variety of stimuli, sizable gaps form
between endothelial cells allowing the passage of large molecules otherwise confined to
the circulation [1–4]. Evidence that the opening of endothelial cell junctions depending
on an active contractile process was first presented by Majno and Palade [5]. These
investigators observed in stimulated post-capillary venules that the endothelial cells
bulged into the lumen and their nuclei developed numerous superficial pleats. Majno
also observed that the endothelial cells expressed a prominent array of fine cytoplasmic
filaments, which he proposed could generate the required contractile force [1, 5]. This
evidence provided a basis for the theory of endothelial cell contractility, while it need
further support. In the early 80’s several laboratories demonstrated gap formation
between cultured endothelial cells upon exposure to thrombin [6–8]. Rotrosen et al.
[9] extended the observation to histamine while Shasby et al. [10] described a more
severe retraction when endothelial cells were exposed to cytochalasin B. Furthermore,
cytokines also induce gap formation that appears indistinguishable from histamine and
thrombin.
Our laboratory has reported on the formation of gaps between endothelial cells
induced by ethchlorvynol, an agent capable of increasing pulmonary capillary perme-
ability and causing pulmonary edema [2,11]. We extended our studies to show similar
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1. INTRODUCTION
effects with histamine, thrombin and PAF [12–14]. In our studies, the shape change is
reversible and there is no injury to the cells. We have also shown that the change in F-
actin associated with shape change of the endothelial cell occurs in an ATP-dependent
manner [15]. Our laboratory used the term retraction initially to avoid any a prior
implication that it requires actomyosin-mediated contractile event. However, we now
know from our permeabilized cell studies [12,15] and from intact preparations [13,14,16]
that endothelial cells possess a myosin light chain kinase (MLCK) controlled contractile
mechanism. Our laboratory has published a method that allows quantitative measure-
ments of contractile force generated by cells grown within a collagen gel or by cells
grown on top of a collagen matrix [14]. We have utilized the phosphorylation hypoth-
esis as a prototype to study the mechanism of endothelial cell contractility [12, 17].
Endothelial cells do not appear to contract in the sense of shortening along a single
axis as smooth muscle cells do. Instead, peripheral regions of the polygonal cell focally
withdraw leaving spaces between adjacent cells which typically remain connected by
tenuous processes [11, 12, 15, 17]. Clues to the mechanism of contraction of endothelial
cells have been provided by such diverse cell types as smooth muscle cells [18–21] fi-
broblasts [13,22–24] RBL cells [25,26] and leukocytes [27] . Smooth muscle cells, unlike
endothelial cells, contract in a polarized fashion.
The common event causing the stimulation of smooth muscle contraction is the
increase in cytosolic free Ca2+. According to the simplest proposed model, Ca2+ as-
sociates with calmodulin and this complex activates MLCK which in turn results in
phosphorylation of myosin light chain (MLC) thus initiating contraction [21, 28]. The
phosphorylation of the 20 kD MLC results in activation of the actin activated Mg-
ATPase activity of myosin which allows myosin to hydrolyze ATP and affect the trans-
formation of chemical energy to mechanical work. Our permeabilized monolayer studies
strongly implicated MLCK and MLC phosphorylation as the mechanism responsible
for initiation of endothelial cell retraction. Our laboratory as well as Garcia’s utilizing
thrombin [29] and studies from Shasby’s laboratory [30] with histamine have confirmed
that stimulation with inflammatory agonists induces MLC phosphorylation.
Myosin light chain kinases are serine/threonine kinases that specifically catalyze the
phosphorylation of serine-19 (Ser19) and threonine-18 (Thr18) in the 20 kD regulatory
light chain of myosin II [31–33]. Phosphorylation of myosin light chain by MLCK is
responsible for initiation of contraction in smooth muscle and leads to potentiation of
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contraction in skeletal muscle [34,35] . However, the function of MLCK and myosin II
in the control of nonmuscle contractility is not well understood. In vitro studies have
suggested that MLCK may control the activity of nonmuscle myosin in nonmuscle cells.
Phosphorylation of Ser19 by MLCK regulates both filament formation [14, 32, 36] and
the myosin II actin activated ATPase activity [18,33] while diphosphorylation of MLC
at both Ser19/Thr18 by MLCK has been implicated in increased filament stability and
has been shown to further increase myosin II ATPase activity in vitro [37] .
So far, investigated vertebrates appear to contain three different isoforms of the con-
ventional nonmuscle myosin II, designated as nonmuscle myosin IIA, myosin IIB and
myosin IIC [38,39]. Although the precise functions of these myosins are not well under-
stood, the mRNA encoding each isoform appears to be consistently expressed across
many tissue and cell lines [40–42]. Since these isoforms are regulated by phosphory-
lation of the 20kD light chains, it is plausible that differential targeting of isoform
phosphorylation dictates unique cellular distributions and/or functions. It has been
well known that myosin IIA is involved in the generation of contraction in nonmuscle
cells and this process requires the actin cytoskeleton, specifically the localized poly-
merization of actin filaments. Myosin IIA is a potent motor protein responsible for cell
contraction, but the specific molecular mechanisms are poorly understood.
Recent study indicates that endothelial barrier integrity depends on the actin and
myosin cytoskeleton [43, 44]. One possible mechanism of increase of vascular perme-
ability is endothelial cell contraction. However, it is not completely understood how
myoactin cytoskeleton is involved in endothelial cell contraction and results in an al-
teration in cell permeability. Understanding the molecular mechanisms of myosin IIA
function in endothelial cells will identify novel therapeutic targets for human diseases
that arise due to defects in endothelial barrier integrity.
In this study, the subject is to explore the role of nonmuscle myosin IIA in en-





2.1 Cell Culture and Reagents
Mouse endothelial cell line obtained from mouse lung tissue was a generous gift of Dr.
Troy Stevens, University of South Alabama.
Cells were cultured in minimal essential media (MEM) supplemented with 10%
heat-inactivated fetal bovine serum, 50 unit/ml penicillin and 50 µg/ml streptomycin
at 37 ◦C under the humidified atmosphere of 5% CO2 and 95% air. Cells were split at
a ratio of 1:4 every 7-8 days.
2.2 Immunofluorescence Microscopy
Control and infected endothelial cells were washed with pre-warmed PBS 3 times, fixed
with freshly made 37 ◦C fixative (1% formaldehyde in stabilization buffer, pH 6.5) for 1
minute at 37 ◦C, followed by incubation with fixation and permeabilization buffer (2%
formaldehyde, 0.2% triton X-100, 0.5% DOC in stabilization buffer, pH 6.5) for 1 hour
at 37 ◦C. Before staining, cultures were washed once with PBS and then permeabilized
in stablization buffer containing 0.5% triton X-100, 0.6% DOC, pH 6.5 for 10 minutes
at room temperature. After permeabilization, cell cultures were washed with PBS 3
times and flooded with 2 ml of blocking buffer (PBS containing 0.8% BSA, 0.5% fish
gelatin, 10 µg/ml IgG) for 1 hour. Blocking buffer was removed and cultures were
incubated with primary antibody in diluted blocking buffer (1:10 dilution) for 3 hours
at room temperature. After primary antibody incubation, cell cultures were washed
with diluted blocking buffer and then incubated with secondary antibody in diluted
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blocking buffer for 2 hours at room temperature. Cultures were washed 3 times with
PBS and coversliped with 90% glycerol/10% PBS containing 0.1 M n-propyl gallate.
Pictures were taken on a Zess 510 confocal microscope and Z series images were built
into composite micrographs.
For staining of myosin IIA + actin or myosin IIB + actin, myosin IIA or myosin
IIB were stained in 0.25 µg/ml affinity purified rabbit polyclonal anti-myosin IIA or
anti-myosin IIB primary antibody and followed by Alexa 488 labeled goat anti rabbit
secondary antibody. Actin filaments were stained with 1.0 µg/ml rhodamine phalloidin
(Sigma, Cat No. P1591) for 1 hour at room temperature. For double staining of myosin
IIA + myosin IIB, myosin IIA was stained with 1.0 µg/ml working concentration of
rabbit polyclonal anti-myosin IIA, followed by Alexa 488 labeled donkey anti rabbit
secondary antibody. Myosin IIB was stained with 1.5 µg/ml working concentration
of affinity purified goat polyclonal primary antibody, followed by Alexa 568 labeled
donkey anti goat secondary antibody.
2.3 Virus Amplification
Adenovirus encoding short hairpin interfering RNA targeting a mouse nonmuscle myosin
IIA (shRNAi-IIA) was amplified in 293T cells. Cells were seeded into T75 cm2 flask
24 hour prior to infection. After achieving 70-80% confluence, 293T cells were washed
3 times with serum free MEM media without penicillin/streptomycin, incubated with
media containing virus at 37 ◦C for 2 hours. After infection, cell cultures were fed with
media (without penicillin/streptomycin) with 10% fetal bovine serum and incubated
at 37 ◦C. After most of the cells become round (about 24 hours post infection), cells
were dislodged by pipeting up and down, media and cells were collected and spun down
at 1000×g (2000 rmp), 4 ◦C for 20 minutes. Cell pellets were re-suspended in 5 ml of
sterile 100 mM Tris buffer (pH8). Cell pellets were frozen in a dry-ice-methanol slurry
and immediately thawed in a 37 ◦C water bath. Cell pellets were processed through 3
freeze-thaw cycles. Cell lysates were spun down at 1000×g (2000 rpm) at 4 ◦C for 20
minutes, supernatant was saved and pellet was discarded.
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2.4 CsCl Purification
CsCl gradients were prepared in SW-40T tubes (Beckman ultra clear tubes, Cat344059):
First, 2.12 ml of 12 g/cc CsCl (26.8 g CsCl in 92 ml of 100 mM Tris buffer PH 8, 10 mM
EDTA) was placed at bottom of SW-40T tube. Then CsCl layer containing 2.82 ml of
1.4 g/cc CsCl (53 g CsCl in 87 ml of 100 mM Tris pH8, 10 mM EDTA) was pipeted
onto the top of 12 g/cc CsCl. 7 ml viral supernatant was gently added on top of CsCl
cushion and spun down at 210,000×g (35,000 rmp) at 4 ◦C for 1hr in the SW-40 Ti
rotor, by using max-start and low brake.
After centrifugation, two distinct bands form the CsCl gradient interfaces. The
bottom band which is white and fluffy at the interface between the 1.4 g/cc and 1.2
g/cc layers was collected with an 18G gauge needle attached to a 5 ml sterile syringe.
The tube was punctured below the band for withdrawing only the viral particles.
A second CsCl gradient in polyallomar quick seal tubes was prepared (Beckman
13x51mm, Cat342412).
Tubes were placed on ice and virus was added to the bottom of each tube, then
1.34 g/cc (13.5 g of CsCl in 30 ml of 100 mM Tris buffer pH 8, 10 mM EDTA) was
added to the top of the dome.
Sealed tubes were spun at 320000×g (60,000 rmp) at 4 ◦C overnight (more than 8
hours) in the rotor VTi65.2.
PD10 columns (PD10 sephadex G25, pre-packed column) were washed twice with
25 ml of sterile 30% glycerol in PBS. After removing tubes from centrifuge, the top of
each tube was punctured to release pressure. A white and fluffy band containing virus
was collected with an 18G gauge needle attached to a 5 ml sterile syringe.
Virus was placed on PD-10 column. 10 ml of 30% glycerol/PBS solution was added
to the column, and 500 µl fractions were collected. All samples were analyzed by
using Nanodrop spectrophotometers at OD 260 nm to determine which fraction contain
purified virus. Virus was stored at -80 ◦C.
2.5 Adenovirus Infection
50,000 cells were seeded onto 35 mm dish pre-coated with 20 µg/ml collagen 24 hours
before infection. For each infected dish, cell cultures were incubated with 1ml MEM
media containing adenovirus (without penicillin/streptomycin and serum) for 2 hours
6
2.6 Western Blot Analysis
at 37 ◦C, then fed with 1 ml MEM media (without penicillin/streptomycin) plus 20%
fetal bovine serum. After 48 hours, old media was removed and cultures were fed
with fresh MEM media (without penicillin/streptomycin) with 10% fetal bovine serum
containing same amount of adenovirus as initial infection. The total infection duration
was 96 hours.
2.6 Western Blot Analysis
Cell cultures were washed 3 times with PBS before harvest. Each culture dish was
flooded with 100 µl of 100 ◦C 1.5×SDS sample buffer containing 10 µg/ml DNase I.
Cells were collected by scraping from the dish with a rubber policeman and transferred
to microfuge tubes.
Cells were sonicated and heated at 100 ◦C for 10 minutes to denature proteins and
samples were stored frozen at -80 ◦C.
SDS samples were run on 10% SDS-PAGE gels and then transferred to PVDF
membrane. 0.1% SDS was included in transfer buffer to help facilitate protein transfer.
Membranes were incubated with the affinity purified primary antibodies against
NMHC IIA (rabbit polyclonal anti-myosin IIA, 0.025 µg/ml), NMHCIIB (rabbit poly-
clonal anti-myosin IIB, 0.025 µg/ml), and GAPDH (Sigma, Cat. No. G8795, mouse
monoclonal, 1:10,000 dilution) at room temperature for 3 hours, followed by incuba-
tion with horseradish peroxidase-conjugated secondary antibodies at 1:5000 dilution
(goat anti rabbit) at room temperature for 1 hour. The immunoblotted proteins were
incubated with ECL reagent and exposed to X-ray film.
2.7 Isometric Tension Measurements
Cells were resuspended in appropriate amount of collagen solution containing fibrinogen
(1 mg/ml rat tail collagen I, 3 mM NaOH, 0.2 mg/ml fibrinogen in DMED media
plus 10% fetal bovine serum) to achieve final concentration of 1 × 106 cell/ml. 2
unit/ml thrombin was added to collagen/cell suspension before being poured into a
Teflon mold with central pole. Molds were incubated at 37 ◦C for 2 hours to allow
collagen polymerization, which initiated the collagen/cell matrix forming a ring.
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Molds were fed with MEM media (with penicillin/streptomycin) plus 10% fetal
bovine serum 2 hours after casting and incubated at 37 ◦C for 24 hours prior to aden-
oviral infection.
After 24 hours, collagen/cell gels were washed twice with MEM media without peni-
cillin/streptomycin and serum before being infected with adenovirus within molds. For
each infected mold, collagen/cell rings were infected by incubating with 1 ml adenovirus-
containing MEM media (without penicillin/streptomycin and serum) for 2 hours at
37 ◦C. Molds were then fed with 2 ml MEM media (without penicillin/streptomycin)
plus 15% fetal bovine serum. After 48 hours infection, media were replaced with fresh
MEM media (without penicillin/streptomycin) with 10% fetal bovine serum plus same
amount of adenovirus as initial infection and incubated at 37 ◦C. Infections were carried
out for a total of 96 hours. After 96 hours incubation, the collagen/cell rings were re-
moved from molds and hanged on isometric force transducer (model 52-9545; Harvard
Apparatus, South Natick, MA). Rings were bathed in 50 ml HEPES-buffered MEM
media supplemented with 10% BSA in a thermoregulated bath at 37 ◦C and pH 7.4.
After baseline force was developed, cell rings were stimulated with 2 unit/ml thrombin.
After achieving stable tension, the cell rings were treated with 2 µM cytochalasin D.
2.8 Attachment and Spreading Measured by ECIS
Control or infected cells were seeded onto ECIS cultureware (100,000 per well, 0.8 cm2
per well) pre-coated with collagen (5 µg/well). The ECIS measurement was started
immediately after cells were seeded into chambers. Cells attached and spread on the
small gold electrode on the bottom of the chamber. A current passed between the
small gold-film electrode and a larger gold counterelectrode. As cultured cells attach
and spread onto the electrodes, the current has to flow in the spaces under and between
the cells which causes the increase in the electrical resistance, as the cell membrane is
essentially an insulator. The total time duration of measurement is 24 hours.
2.9 Cell Motility
Control or infected cells were seeded onto 35 mm dish (50,000 per dish) and subjected
to cell motility measurement by Nikon Swep Field confocal system 24 hours after cast-
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ing. The total time duration of measurement is 5.5 hours. The centroid position (x, y)
of each cell was tracked at each 60-second interval for the entire duration of the ex-
periment. Cells that migrated out of the image field as well as divided during the
experiment were excluded from the calculation. The speed of migrating cell was cal-






In order to determine the optimal condition for reducing the level of myosin IIA in
mouse endothelial cells, experiments were undertaken to assess the appropriate incuba-
tion dose and time needed to reduce nonmuscle myosin IIA using adenovirus encoding
an shRNAi to nonmuscle myosin IIA in cells.
Figure 3.1: Dose-dependent experiment - Figure presents the result of western blot
of cell lysate from mouse endothelial cell cultures infected with different amount of ad-
shRNAi-IIA (1=MOI 12.5 per cell, 2=MOI 25 per cell, 3, 3’=MOI 50 per cell, 4, 4’=MOI
100 per cell, 5, 5’=MOI 200 per cell, prime indicates duplicate loading). Increasing virus
dosage resulted in a steady decrease in myosin IIA expression reaching maximal myosin
IIA knockdown at MOI 100 per cell.
Figure 3.1 is a representative western blot of cell lysate from mouse endothelial cell
cultures infected with different amount (MOI 12.5 per cell, MOI 25 per cell, MOI 50 per
cell, MOI 100 per cell, MOI 200 per cell) of adenovirus encoding sh-RNAi-IIA. Western
Blots were probed with affinity purified antibody to myosin IIA. As shown in figure 1,
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the shRNAi-IIA probe is effective in reducing endogenous endothelial cell myosin IIA.
Low dosage of virus had a minimal effect on myosin IIA levels, while increasing doses
resulted in a steady decrease in myosin IIA, reaching maximal IIA knockdown at MOI
100 per cell. For quantitative analysis, the myosin IIA knockdown was ratioed to the
level of GAPDH in cell extracts.
Myosin IIA levels were reduced by 26% in cultures incubated with MOI 12.5 per
cell, 56% in cultures incubated with MOI 25 per cell and 62% in cultures incubated
with MOI 50 per cell, while in cultures incubated with MOI 100 per cell and MOI 200
per cell a maximal 82% reduction occured. From these results, a dose of MOI 100 per
cell ad-shRNAi-IIA was chosen for use in all experiments.
After establishing the appropriate dose, experiment was undertaken to determine
the time duration for maximal reduction of myosin IIA levels. Mouse endothelial cells
were infected with MOI 100 per cell for 48 hours, 72 hours and 96 hours. After appro-
priate time intervals, both control and infected cell cultures were harvested, and cell
lysates were analyzed by western blot for myosin IIA expression level.
After 48 hours incubation with virus, the myosin IIA level was reduced by 48%.
Further increasing the incubation time to 72 hours and 96 hours, we achieved a re-
duction in myosin IIA of 71% and 81% respectively (figure 3.2). Maximal reduction of
myosin IIA occurred after 96 hours incubation with ad-shRNAi-IIA.
Figure 3.2: Time-course experiment - Mouse endothelial cells were infected with
MOI 100 per cell for 48 hrs, 72 hrs and 96 hrs. Western blot of cell lysates from mouse
endothelial cell cultures showed maximal reduction of myosin IIA occurred after 96 hrs
incubation with ad-shRNAi IIA.
To confirm the dose response and time course experiments, cells were infected with
a dose of MOI 100 per cell for 96 hour. Cells lysates were analyzed by western blot as
shown in Figure 3.3.
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Figure 3.3: Confirmation of optimal condition for infection - Mouse endothelial
cells were infected with a dose of MOI 100 per cell for 96 hour and a 90% reduction in
myosin IIA content occurred in respond.
After 96 hours, a 90% reduction in myosin IIA content occurred in respond to a
dose of MOI 100 per cell as shown in figure 3.3 A.
Since myosin IIA and myosin IIB heavy chains have similar structural characteris-
tics, cell lysates were probed with affinity purified myosin IIB antibody to ensure that
our IIA probe had no effect on myosin IIB content. As shown in figure 3.3 B, incubation
of cells with adnovirus encoding shRNAi-IIA had no effect on myosin IIB content while
reducing myosin IIA levels by 90% (figure 3.3 B).
3.2 Myosin II and Actin Localization in Preconfluent En-
dothelial Cells
It’s well-known that nonmuscle myosin II and F-actin have a fundamental role in regu-
lating cell shape, motility and force development. In tissue culture dishes preconfluent
endothelial cells assume various shapes with different cytoskeletal organization. As
cells grow, divide and contact one another, their cytoskeleton continuously changes
until reaching a stable configuration 5-6 day after being seeded onto culture dishes.
At confluence endothelial cells form a sheet of polygonal cells tightly attached to one
another forming a semi-permeable membrane that regulates the movement of solutes
across the monolayer. Since, endothelial cells change shapes as they grow, we sought
to determine the structural differences in myosin II and actin organization in endothe-
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lial cells 24 hours after seeding from endothelial cells within a confluent monolayer 5
day post seeding. Figure 3.4 illustrates the distribution of myosin IIA and actin and
figure 3.5 myosin IIB and actin within representative cell morphologies identified in
culture. Actin filaments for the most part were bundled into stress fibers that ran
parallel to the long axis of the cell. In one group of cells (Fig. 3.4A and 3.5A) there
was a complex array of paranuclear actin filaments with small filaments emanating
radialy for this complex. In a second group (Fig. 3.4B and 3.5B) the actin filamants
varied in length, ran parallel to one another but had no paranuclear actin complex. In
the last group identified Fig. 3.4C and 3.5C actin filaments appeared to arise from a
paranuclear array of filaments and coursed toward the periphery of the cell in a radial
spoke like pattern. Both myosin IIA (Fig. 3.4) and IIB (Fig. 3.5) were associated with
the underlying actin filaments however myosin IIA was more concentrated within the
paranuclear actin arrays.
To determine if myosin IIA has a role in forming and maintaining these structures,
experiments were undertaken to knock down myosin IIA in endothelial cells and deter-
mine what effects loss of myosin IIA had on the cellular cyto-architecture. Endothelial
cells were infected with a adenovirus encoding a shRNAi to myosin IIA, cells were har-
vested 96 hours post infection and seeded at preconflunet densities fixed 24 hrs after
seeding and stained for either myosin IIA/actin (Fig. 3.6) or myosin IIB/actin (Fig.
3.8) staining. Parallel dishes were harvested for SDS gels analysis to determine the
extent of myosin IIA knock down (Fig. 3.7A) and to show shRNA-IIA constructs did
not alter myosin IIB protein levels (Fig. 3.7B). Treatment of cultures with our aden-
ovirus encoding shRNAi-IIA at MOI 100 per cell resulted in 90% reduction of myosin
IIA with no significant affect on myosin IIB levels (Fig. 3.7B). Immunofluoresent local-
ization studies showed major reductions in myosin IIA levels within all cells compared
to controls (Fig. 3.4). However, the total amount of IIA loss varied somewhat from
cell to cell. Two levels of NMHC-IIA knock down cells were identified. Fig. 3.6A illus-
trates a representative cell where negligible amounts of myosin IIA remain within the
cytoplasm. The lingering myosin IIA is randomly dispersed throughout the cytoplasm
taking on no distinct pattern. Cells with this phenotype were larger in size and display
large protruding lamella from different regions of their cell body. Co-staining these cells
with rhodamine phalloidin showed loss of NMHC-IIA has a striking effect on underly-
ing actin stress fibers. The ordered stress fiber organization within the cytoplasm was
13
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Figure 3.4: Myosin IIA and actin localization in control cells - Preconfluent
endothelial cells were stained for myosin IIA and actin. Endothelial cells were fixed 24
hours post seeding. Bar, 20 µm.
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Figure 3.5: Myosin IIB and actin localization in control cells - Preconfluent




Figure 3.6: Myosin IIA and actin localization in preconfluent cells infected with
ad-shRNAi-IIA - Loss of myosin IIA induced loss of stress fibers, which cause significant
changes in actin organization and cell shape. Bar, 20 µm.
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Figure 3.7: Myosin content in ad-shRNAi-IIA infected endothelial cells - Myosin
II A level was dramatically decreased in ad-shRNAi IIA infected cells, while myosin IIB
was not affected.
lost. Stress fiber that remain were short filaments randomly orientated concentrated
near the nuclear region while membrane protrusions were filled with a fine reticular
meshwork of actin filaments (Fig. 3.6A). The majority (>85%) of infected cells ex-
hibited this phenotype. About 15% of the cells observed still had detectable myosin
IIA present within the cytoplasm. Myosin IIA localized at the cell periphery and as-
sociated with underlying actin filaments. Actin filament structure was disorganized,
however, the number of actin filaments present in cells and the degree of disruption
did not directly correlate with the extent of myosin IIA knock down. The content of
myosin IIB minimally changed in NMHC-IIA knock down cells (Fig. 3.7B). Myosin
IIB co-localized with the actin stress fibers and the fine actin meshwork that formed in
myosin IIA knock down cells (Fig. 3.8A-C). These results confirmed the specificity of
Ad-shRNAi knock down construct and showed that myosin IIB association with actin
appeared unaltered in NMHC-IIA knock down cells.
In order to directly compare the localization of myosin IIA and myosin IIB in control
and NMHC-IIA knockdown endothelial cells, cultures were fixed and double stained for
myosin IIA and myosin IIB. As shown in figure 3.9 myosin IIA and myosin IIB exhibited
a sarcomeric like distribution associated with the underlying actin filaments. This was
the same distribution found in untreated control cells stained for myosin IIA/actin and
17
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Figure 3.8: Myosin IIB and actin localization in preconfluent cells infected
with ad-shRNAi-IIA - Cell shapes were changed dramatically while myosin IIB still
associated with actin. Bar, 20 µm.
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IIB/actin alone (Fig. 3.4 and 3.6). NMHC-IIA knock down resulted in disruption but
not complete loss of actin stress fibers. Myosin IIB associated with stress fibers as well
as the fine actin network that formed within the cell cytoplasm. Staining for myosin
IIA/IIB/actin in control and myosin IIA knockdown cultures confirmed our previous
results.
Figure 3.9: Double staining for myosin IIA and myosin IIB - Control and ad-
shRNAi-IIA infected cells were double stained for both myosin IIA and myosin IIB (myosin
II A is in green and myosin IIB is in red in merge picture). Bar, 20 µm.
3.3 Myosin II and Actin Localization in Confluent Mono-
layers
Since the confluent endothelial cell monolayer is believed to be a model representative
of endothelial cells lining blood vessels, we sought to determine if loss of myosin IIA
alters endothelial cell monolayer cytoskeletal structure. Result from myosin IIA / actin
staining of control and ad-shRNAi-IIA infected confluent endothelial monolayers is
presented in figure 3.10. In untreated controls, myosin IIA was localized to the cell
margins outlining individual cell within monolayers as well as within the cytoplasm as
small droplets or rods like structures. F-actin concentrated at cell boarders and formed
stress fibers throughout the cytoplasm. Loss of myosin IIA did not cause monolayers
to lift off the culture dishes nor cause large gaps to form between individual cells.
Besides a slight change in cell shape, monolayers appeared unaffected as examined by
light microscopy. In contrast, monolayers infected with ad-shRNAi-IIA and stained for
19
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myosin IIA/actin showed loss of myosin IIA from the cell margins while small aggregates
of myosin IIA staining material formed within the cytoplasm. The actin localization at
the cell periphery was also lost while the cytoplasmic stress fibers appeared shorter and
more disorganized. In control, monolayers myosin IIB localized to the boarders between
cells similar to that seen with myosin IIA (Fig. 3.11). Small droplets of myosin IIB were
also distributed throughout the cytoplasm. F-actin localized to the cell margins and
central stress fibers and myosin IIB was found decorating their structures. In myosin
IIA knocked down cells, myosin IIB appeared minimally altered. Myosin IIB remained
localized at cell margins. However, myosin IIB appeared to associate more prominently
with central stress fibers.
Figure 3.10: Myosin IIA and actin localization of control and ad-shRNAi-
IIA infected confluent monolayers - The result presented that loss of myosin at cell
periphery affected organization of actin fiber. Bar, 20 µm.
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Figure 3.11: Myosin IIB and actin localization of control and ad-shRNAi-IIA
infected confluent monolayers - Myosin IIB localization was not affected by loss of
myosin IIA, even though cells appeared larger and more spread. Bar, 20µm.
21
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3.4 Cell Attachment and Spreading
Knocking down of myosin IIA alter both the actin and myosin II cytoskeleton in both
pre-confluent and post confluent endothelial cells. Since, the cytoskeleton is critical
for cell attachment and spreading and we wanted to determine if reorganization of the
cytoskeleton altered the rate and degree of endothelial cell attachment and spreading.
For these experiments we used Electric Cell-substrate Impedance Sensing (ECIS) mea-
surements to follow changes in cell attachment and spreading in control and infected
endothelial cells.
Collagen coated ECIS culture chambers were placed in the ECIS apparatus. Con-
trol and ad-shRNA-IIA infected mouse endothelial cells were seeded into chambers
and measurements started immediately. Figure 3.12 shows representative cell attach-
ment and spreading tracings for control (uninfected), negative control (cell treated
with non-targeting virus) and myosin IIA knockdown cells. No significant difference in
cell adhesion was detected within the first 15 minutes. By 30 minutes, the myosin IIA
knockdown cells showed a greater increase in electrical resistance suggesting that either
more cells had adhered to the substratum or the myosin IIA knockdown cells spread
faster. Myosin IIA knockdown cells continued to show an increase in resistance over
the ensuing 12 hour compared to controls suggesting knockdown cells spread faster or
were bigger than the control cells. After 12 hours, knockdown cells exhibited a stable
resistance while the control cell lines continued to develop resistance, suggesting control
cells were forming a tighter or more cohesive layer. These experiments suggested that
loss of myosin IIA initially accelerated cell spreading allowing for greater coverage of
the ECIS chamber and resulting in an increase in resistance compared to the paired
controls. However, as the cells continued to spread/grow, it appeared that myosin IIA
was needed for development of a cohesive endothelial cell monolayer.
3.5 Myosin IIA and Endothelial Cell Motility
Our result showed myosin IIA was involved in modulating cell adhesion and spread-
ing, which were early events in cell migration. To determine the role of myosin IIA in
endothelial cell migration, experiments were undertaken to directly measure the rate
of endothelial cell movement in control and myosin IIA knockdown endothelial cells.
50,000 control or myosin IIA knockdown cells were seeded onto dishes and allowed to
22
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Figure 3.12: Endothelial cell attachment and spreading - Myosin IIA knockdown
cells (black curve) initially had a larger slope than that of control curves. With time, the
slope decreased, suggesting a lower cell adhesion function or cell division rate in infected
cells than control cells.
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adhere and spread for 12 hours before motility measurements were performed. Cul-
tures were washed with media containing 0.25% BSA 30 minutes prior to the start
of an experiment to remove virus. Parallel cultures were maintained under identical
conditions to assess the effects of the adenovirus constructs on the levels of myosin IIA.
Western blot analysis showed that cells treated with adenovirus encoding shRNAi-IIA
showed a 80% reduction of myosin IIA levels (Fig. 3.15). Figure 3.13 depicts a rep-
resentative control motility movie showing the movement of endothelial cell every 30
minutes over a 5.5 hour time frame. After starting motility movie, pictures were cap-
tured every 60 seconds and the rate and path of cell migration were tracked at thirty
minutes intervals for a total of 5.5 hours. The red dot placed on a cell at time zero
allows one to follow the motility of an individual cell over the time frame outlined in
specific protocols. Migration of control endothelial cell is depicted in Fig. 3.13 while
the migratory path of myosin IIA knockdown cells is shown in Fig. 3.14. The rate of
cell movement (µm/hr) is shown in Table 3.1. Myosin IIA knockdown cells (Fig. 3.14)
were more spread and bigger than control cells (Fig. 3.13), which was consistent with
the results we observed in static cultures. In addition, myosin IIA knockdown cells
moved 35% faster (13.54±5.34 µm/hr) than control cells (8.69±5.41 µm/hr). These
results suggested myosin IIA limited the rate of endothelial cell motility and loss of this
molecule resulted in unfettered motion.
Average Velocity (µm/hr)
Control 8.69 ± 5.41
IIA knockdown 13.54 ± 5.34
Table 3.1: Effect of loss of myosin IIA on endothelial cell motility - Result
indicated that loss of myosin IIA increase cell motility.
To further analyze the cell motility, Fig. 3.16 illustrated the positions of cells at
30 minute interval for the duration of experiment. One axis is angular data (degree),
another axis is radial data (µm). The control endothelial cells tended to stay near
the point of origin which indicated that most control cells barely moved during the
5.5 hour time lapse experiment. On the other hand, endothelial cells infected with
ad-shRNAi-IIA displayed greater movement with variable directions and considerable
distance. This phenomenon of increased cell migration suggested that loss of nonmuscle
myosin IIA might increase endothelial cell motility.
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Figure 3.13: Motility of control cells - Pictures were taken every 30min for the first
5.5 hours. Red dot was added to help track one cell movement. No apparent net movement
was observed as shown.
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Figure 3.14: Motility of ad-shRNAi-IIA infected cells - Pictures were taken every
30min for 5.5 hours. Red dot was added to help track one cell movement. It showed that
cell shapes were changed apparently compared to control.
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Figure 3.15: Effect of ad-shRNAi-IIA infection on myosin IIA content - Myosin
II A level was clearly dereased in ad-shRNAi-IIA infected cells.
3.6 Effects of Myosin IIA on Isometric Tension
Since, actin and myosin are responsible for generating endothelial cell contractile forces
[48], we sought to determine if loss of myosin IIA alters the contractile force produced
by endothelial cells. In this last set of experiments, we directly measured the contractile
force produced by endothelial cell depleted of myosin IIA. Isometric tension measure-
ments were performed as outlined by Goeckeler and Wysolmerski [14]. Representative
force tracings are shown in Fig. 3.17. Depletion of myosin IIA (green tracing) resulted
in about 41% reduction in baseline tension compared to control (red tracing). Both
myosin IIA knockdown and control monolayers rapidly increased their isometric tension
upon stimulation with thrombin. However, myosin IIA depleted monolayers produced
about 33% less force than control. Taken together, these results indicate that myosin




Figure 3.16: Path of cell movement - angular data (degree) vs radial data (µm).
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Figure 3.17: Force measurement of control and ad-shRNAi-IIA infected cells
- Red line presented control cells, the green line presented ad-shRNAi-IIA infected cells.
After the baseline force was reached, the cells were stimulated with 2 unit/ml thrombin,
which induced a rapid increase in tension. After achieving peak tension, tension dropped
to establish a new baseline force. Application of cytochalasin D (Cyto D) depolymerized





This study analyzed the role of nonmuscle myosin IIA in regulating endothelial cell
shape, motility and contraction by knocking down nonmuscle myosin IIA in endothelial
cells with ad-shRNAi-IIA. The western blot result presented that about 90% percent
of nonmuscle myosin IIA expression was decreased after MOI 100 per cell infection
for 96 hours and it also showed that that nonmuscle myosin IIA expression could be
effectively depleted without affecting the levels of the nonmuscle myosin IIB isoform.
Jeon et al. [49] provide evidence that nonmuscle myosin II is responsible for es-
tablishing cell polarity and retaining the cellular structure. The regulatory site of
nonmuscle myosin regulatory light chain (MRLC) is directly phosphorylated by AMP-
kinase, which is an enzyme activated in response to energy deprivation. These inves-
tigators observed that the defect of AMP-kinase can lead to failure of activation of
nonmuscle myosin II and dramatic abnormalities in cellular structure. However, after
activation of AMP-kinase, they observed actin cytoskeleton polarization and dramatic
changes in cell shape. Our morphology analyses were consistent with their observa-
tions that knocking down nonmuscle myosin IIA dramatically changed the cell shape
and myoactin cytoskeleton. Our results provide further evidence that knocking down
nonmuscle myosin IIA in endothelial cells causes decrease in number of F-actin bundles
and increase of fine actin meshwork, which is also consistent with the observations of
Sandquist et al [50].
Cell motility was analyzed in several experiments here, involving initial attachment
and spreading measured by ECIS and random migration after attachment, measured
by live cell imaging by Nikon swept field confocal system. In the ECIS result, myosin
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IIA knockdown cell presented a higher resistance during initial attachment, which in-
dicated a faster attachment in myosin IIA knockeddown cells than control cells. This
result is consistent with earlier conclusions Jay et al. [51] presented that myosin II con-
tributes to cellular detachment and retraction, and Wylie and Chantler [52] deduced
that nonmuscle myosin IIA drive neurite retraction in neuronal cells. Consistent with
these conclusons, in the following random migration experiment by using Nikon swept
field live cell confocal system, cells were observed more spread and larger in myosin IIA
knockeddown cells and the moving rate of random migration was slightly higher than
control cells.
Normally, contraction force helps detach the cell tail from the substratum. Since
previous result demonstrated that the cellular detachment and retraction were inhib-
ited in myosin IIA knockdown cells, we predicted that the contraction force will be
decreased in myosin IIA knockeddown cells. In our laboratory, its observed that loss of
nonmuscle myosin IIA not only cause morphology changes, it can also affect isometric
tension production in endothelial cell. Our force measurement data showed that loss of
myosin IIA can induce decrease in both baseline force and agonist-stimulated isometric
tension produced in endothelial cells compared to control cells (Fig. 3.17). And the par-
allel western blot result also indicated that myosin IIA level was significantly decreased
in ad-shRNAi-IIA infected cells while myosin IIB level was not affected by myosin IIA
knockdown. These results suggested that the baseline force and agonist-stimulated
isometric tension produced in myosin IIA knockdown cells may result primarily from
nonmuscle myosin IIB. In the absence of myosin IIA, myosin IIB can still produce con-
siderable baseline force and agonist-stimulated isometric tension force. We concluded
that both myosin IIA and IIB contribute to the cell contractility of endothelial cell
in normal condition. Loss of myosin IIA will result the decrease in the total baseline
force produced as well as agonist-stimulated isometric tension force produced. In the
absence of myosin IIA, can myosin IIB maintain contractile force to the same degree
as in control cells or increase force production to partially compensate for the loss of
the myosin IIA needs to be determined.
In our laboratory, we are also interested in the effect of loss of myosin IIB on
endothelial cells. More surprising was our finding that in myosin IIB knockdown cells,
actin filaments within the cytoplasm were not disrupted or lost like what we observed
in myosin IIA knockdown cells previously stated. Myosin IIB deficient cells displayed
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regular cell shape and cytoskeleton, and actin filaments were bound into stress fibers
running through cytoplasm. In addition, cells maintained their regular shapes, no
exaggerated membrane protrusion occured. Taken together, loss of nonmuscle myosin
IIA in endothelial cells leads to disruption of stress fibers resulting in apparent changes
in cell shape and membrane protrusions. Meanwhile, different from those phenotypes
in myosin IIA knockdown cells, in endothelial cells with ablation of nonmuscle myosin
IIB while exclusively express nonmuscle myosin IIA isoform, cells displayed normal cell
shape and actin filament. One hypothesis is that the stabilization of stress fiber as
well as maintenance of cell shape depends heavily on nonmuscle myosin IIA, which is
responsible for interacting with actin filaments and other cross-link proteins to form
high order stress fibers in cells. In myosin IIA knockdown cells (Fig. 3.8), myosin
IIB colocalized with short and disorganized stress fibers, suggesting that nonmuscle
myosin IIB also contributes to stress fiber development, but might not be sufficient in
maintenance the high order structure when nonmuscle myosin IIA is ablated from cells.
In summary, our data have shown that knocking down the expression of nonmuscle
myosin IIA in mouse endothelial cells causes a dramatic decrease of stress fiber as well
as alteration of actin cytoskeleton organization with concomitant changes in cell shape,
migration and contractile force. Our data consistant with previous work by other
investigators provided strong evidence supporting the idea that nonmuscle myosin IIA
plays an important part in regulating cell shape, motility and contraction. More work
is required for a further understanding of how these activities are monitored by the
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